We are live on ! Find out more
PNT

POINT Biopharma Global Inc. Common Stock
PNT

Delisted

PNT was delisted on the 26th of December, 2023.

Back to rankings

1 hedge funds and large institutions have $1K invested in POINT Biopharma Global Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 124 closing their positions.

New
Increased
Maintained
Reduced
Closed

18,472% more call options, than puts

Call options by funds: $8.54M | Put options by funds: $46K

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 124

99% less funds holding

Funds holding: 125 → 1 (-124)

100% less capital invested

Capital invested by funds: $411M → $1K (-$411M)

Holders
1
Holders Change
-124
Holders Change %
-99.2%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
124
Calls
$8.54M
Puts
$46K
Net Calls
+$8.5M
Net Calls Change
+$9.58M

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$1.65K

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$70.5M
2
BlackRock
BlackRock
New York
-$44.3M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$31.1M
4
State Street
State Street
Massachusetts
-$23.5M
5
GPP
Great Point Partners
Connecticut
-$19.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
YC
76
Yarbrough Capital
Tennessee
– -$281K -42,130 Closed
PA
77
Profund Advisors
Maryland
– -$257K -38,551 Closed
Franklin Resources
78
Franklin Resources
California
– -$252K -37,832 Closed
VOYA Investment Management
79
VOYA Investment Management
Georgia
– -$245K -36,733 Closed
T. Rowe Price Associates
80
T. Rowe Price Associates
Maryland
– -$244K -36,531 Closed
Hudson Bay Capital Management
81
Hudson Bay Capital Management
Connecticut
– -$241K -36,066 Closed
Manulife (Manufacturers Life Insurance)
82
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$239K -35,766 Closed
LPL Financial
83
LPL Financial
California
– -$226K -33,925 Closed
Marshall Wace
84
Marshall Wace
United Kingdom
– -$206K -30,958 Closed
Principal Financial Group
85
Principal Financial Group
Iowa
– -$200K -30,000 Closed
Jane Street
86
Jane Street
New York
– -$190K -28,498 Closed
CIC
87
Cornercap Investment Counsel
Georgia
– -$190K -28,474 Closed
Royal Bank of Canada
88
Royal Bank of Canada
Ontario, Canada
– -$184K -27,621 Closed
New York State Common Retirement Fund
89
New York State Common Retirement Fund
New York
– -$182K -27,257 Closed
Susquehanna International Group
90
Susquehanna International Group
Pennsylvania
– -$175K -26,183 Closed
State Board of Administration of Florida Retirement System
91
State Board of Administration of Florida Retirement System
Florida
– -$174K -26,070 Closed
GHA
92
GW Henssler & Associates
Georgia
– -$160K -24,056 Closed
FWP
93
Firethorn Wealth Partners
Georgia
– -$145K -21,705 Closed
Two Sigma Advisers
94
Two Sigma Advisers
New York
– -$135K -20,200 Closed
PIC
95
Portland Investment Counsel
Ontario, Canada
– -$133K -20,000 Closed
ASRS
96
Arizona State Retirement System
Arizona
– -$120K -18,056 Closed
Teacher Retirement System of Texas
97
Teacher Retirement System of Texas
Texas
– -$120K -18,016 Closed
WG
98
Winton Group
United Kingdom
– -$107K -16,056 Closed
Squarepoint
99
Squarepoint
New York
– -$107K -16,016 Closed
ETC
100
Exchange Traded Concepts
Oklahoma
– -$94.4K -14,160 Closed
1 2 3
4
5

PNT Hedge Fund Activity: Q4 2023 in Review

1 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in POINT Biopharma Global Inc. Common Stock (PNT) for Q4 2023, worth a combined $1K — down 100% from $411M a quarter earlier.

Sellers outnumbered buyers: 124 funds closed out of PNT and 1 opened new positions — a net loss of 123 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Blue Trust Inc, opening a new position worth an estimated $1.65K. The largest seller was BVF Inc, exiting entirely with an estimated $70.5M sold.

  • 1 institutional investor held POINT Biopharma Global Inc. Common Stock (PNT) as of Q4 2023, down from 125 in Q3 2023.
  • Funds reported $1K of POINT Biopharma Global Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
  • 1 fund opened new POINT Biopharma Global Inc. Common Stock positions in Q4 2023 and 124 closed out, a net change of -123 holders.
  • The largest POINT Biopharma Global Inc. Common Stock buyer in Q4 2023 was Blue Trust Inc, an estimated $1.65K added.
  • The largest POINT Biopharma Global Inc. Common Stock seller in Q4 2023 was BVF Inc, an estimated $70.5M sold.

Based on aggregated 13F filings for Q4 2023.